Safety and Efficacy of the Noncessation Method of Antithrombotic Agents after Emergency Endoscopic Hemostasis in Patients with Nonvariceal Upper Gastrointestinal Bleeding: A Multicenter Pilot Study

Table 2

Types of antithrombotic agents taken by patients in group A.

Number of antithrombotic agents	43
Single agent	32 (74.4%)
Multiple agents	11 (25.6%)
Types of antithrombotic agents
Antiplatelet agents
Aspirin	17 (39.5%)
Clopidogrel	11 (25.6%)
Sarpogrelate	3 (7.0%)
Prostaglandin preparations	2 (4.6%)
Prasugrel	2 (4.6%)
Cilostazol	1 (2.3%)
Anticoagulant agents
DOACs	12 (27.9%)
Edoxaban	6 (14.0%)
Apixaban	4 (9.3%)
Rivaroxaban	2 (4.6%)
Warfarin	5 (11.6%)

DOACs: direct oral anticoagulants. Group A: patients taking antithrombotic agents who underwent emergency endoscopic hemostasis for nonvariceal upper gastrointestinal bleeding and resumed antithrombotic medication without a cessation period.